PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
24-Apr-2025 ViroCell manufactured a GMP lentiviral vector for UCL to accelerate research into prevention of relapse in childhood blood cancer ViroCell
24-Apr-2025 Zelluna Reaches Major Milestone with Manufacturing Process Established in Preparation for Clinical Entry of ZI-MA4-1, its Novel TCR-NK Therapy Targeting Solid Tumours Zelluna
24-Apr-2025 EMAS Pharma Rebrands as Evestia Clinical Evestia Clinical
23-Apr-2025 Transgene to Provide Updated Phase I Data in a Rapid Oral Presentation on Individualized Therapeutic Cancer Vaccine TG4050 at ASCO 2025 Transgene
23-Apr-2025 Dr. Stephan Rietiker elected as new Chairman of the Board of MetrioPharm AG MetrioPharm
21-Apr-2025 Integrated DNA Technologies Introduces Transformative Hybridization Capture Solution to Accelerate Cancer Research Integrated DNA Technologies
17-Apr-2025 Announcement by Malfy Tech Malfy Tech
16-Apr-2025 Duchenne Muscular Dystrophy: diagnosis, clinical development and global research myTomorrows
15-Apr-2025 CluePoints’ Technology Named as Finalist in 2025 Citeline Awards CluePoints
15-Apr-2025 1ST Biotherapeutics Joins The Michael J. Fox Foundation’s LITE Program to Advance LRRK2-Based Parkinson’s Disease Research 1ST Biotherapeutics
14-Apr-2025 New GDP Training with Certificate Pharma Lessons
11-Apr-2025 PIVOTAL has been awarded by ADEFAM the Special Mention Award for the Most innovative Business Project of the Year 2025 PIVOTAL
11-Apr-2025 Evestia Clinical - the new brand identity for EMAS Pharma - launches today as a market leading pharmaceutical research specialist focused on Clinical Trials in Oncology and Rare Diseases Evestia Clinical
10-Apr-2025 Phastar Secures Finalist Spot at 2025 Citeline Awards Phastar
09-Apr-2025 ESCMID Global 2025: Shionogi presents real-world data demonstrating better clinical outcomes when Fetcroja® / Fetroja® (cefiderocol) is used as empiric or documented therapy as compared to salvage therapy for the treatment of Gram-negative bacterial infections Shionogi & Co. Ltd.
09-Apr-2025 ENA Respiratory Partners with University of Maryland and Leading Respiratory Disease Expert to Conduct Phase 2 Study of INNA-051 Antiviral Host Defence Enhancer ENA Respiratory
09-Apr-2025 Infinitopes Granted Phase I/IIa Clinical Trial Application Approval to Evaluate Precision Vaccine Targeting Early-Stage Oesophageal Cancer Infinitopes
09-Apr-2025 Ebenbuild Contributes Cutting-Edge Digital Lung Simulations to Pulmonary Fibrosis Drug Development Ebenbuild
03-Apr-2025 Creative Diagnostics Expands Hepatitis B Research Tools with High Performance HBV Surface Antigen L-Proteins Creative Diagnostics
03-Apr-2025 Creative Diagnostics Announces Antiviral Drug Discovery Services to Accelerate Therapeutic Development Creative Diagnostics